Psycheceutial Biosciences (BWVI) Listed on WeFunder!
Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated.
Imagine the benefits of psychedelics, without hallucinating!
Our Favorite small Psychedelic company Psycheceutical Bioscience is using...
Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction
“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.”
Known as the “Psychedelic Concierge...
Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?
A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice
Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery...
COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement
Transaction led by healthcare specialist investors, TCGX and Aisling Capital
$125 million financing upfront with up to an additional $160 million tied to exercise of...
Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.
Cohen Psychedelic Research & Health Initiative
Cohen Foundation Awards $5 Million for MDMA Therapy Approval
Millions of Americans suffer from depression, anxiety, addiction, post-traumatic stress disorder...
Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...
Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests NeuroDirect™ Ketamine....
Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials
Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD.
Company raises $1.3M USD convertible note from Cantheon Capital for in-human trials...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of applying NeuroDirect™ ketamine topical...
Video: New Topical Drug Delivery System, NeuroDirect™
Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs.
https://youtu.be/2CGT7P9QEvo
Can this be used for Ketamine treatments? Time will tell, as they are...
Topical PTSD Drug Poised for Human Trials.
In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid and psychedelic...
Latest article
Cardiol Therapeutics (CRDL) May 2025 Presentation.
Click here to open.
RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview
Nice Bounce on Alkaline Water (WTER) up 81%.
Well now that ain't bad, up 81%!
Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...
Zomedica Corp (ZOMDF) $0.05
Company Overview
Background
Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...
